## IEX: IDEX Corporation - XLI: Industrials

### Executive Summary

No thesis match: MRS_20 0.7% below STRENGTH zone (4.0-10.0%); PEG 1.74 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-2.8% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($171.12)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 2
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. IDEX (IEX): A Fresh Look at Valuation After Recent Share Price Rebound**
- Source: Simply Wall Street | 20251217T122905 | Bullish | Relevance: 100%
- IDEX (IEX) has seen an 11% share price rebound over the last three months, despite negative year-to-date and one-year returns, prompting a fresh look at its valuation. The company is considered 9% undervalued with a narrative fair value around $190s, based on expected earnings growth to $698.2 million by Sept 2028. However, an "Another View" perspective suggests caution, as its current PE ratio of 27.7x is richer than peers and a fair ratio.

**2. Corient Private Wealth LLC Lowers Stock Position in IDEX Corporation $IEX**
- Source: MarketBeat | 20251217T085730 | Neutral | Relevance: 93%
- Corient Private Wealth LLC reduced its stake in IDEX Corporation (NYSE:IEX) by 3.6% in the second quarter, now owning 221,792 shares valued at $38.94 million. Other institutional investors like Thurston Springer Miller Herd & Titak Inc. and American National Bank & Trust also adjusted their positions in the industrial products company. IDEX Corporation recently declared a quarterly dividend of $0.71 per share and announced a $1 billion share repurchase plan.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-08 | Citigroup | $202 | $197 | +3% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-08 | Citigroup | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 1 ($0.10M) |
| Sells | 0 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 50.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 12.1% (-1.1%)
- Wellington Managemen: 8.6% (+3.4%)
- Blackrock Inc.: 7.6% (-1.8%)
- Morgan Stanley: 4.5% (+7.6%)
- State Street Corpora: 4.2% (+1.8%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-2.8% 5d) with bearish MACD, trend may be turning.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.74 elevated, pricing in significant growth expectations. Forward P/E 21.4x stretched relative to 5% growth. Balance sheet: strong liquidity (2.9x). Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $13.4B |
| Beta | 1.00 |
| 52W Range | $153.36 - $226.05 |
| Short Interest | 4.0% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.74 |
| Forward P/E | 21.4 |
| Current P/E | 22.5 |
| YoY Growth | 5.5% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 3.6% to 0.7% (-2.8% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 3.3pp (needs >4.0% for momentum thesis). MRS_5 (-1.0%) diverging from MRS_20 - short-term weakness emerging. Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 58. Elevated volume (1.6x 20MA), institutional activity likely. OFD pattern: -DBH (Indecision).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 0.73% (CS: 58) | Neutral |
| RSI_14 | 58.5 | Neutral |
| MACD Histogram | -0.16 | Bearish |
| vs SMA20 | 1.011x | Above |
| vs SMA50 | 1.044x | Above |
| vs SMA200 | 1.028x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $177.86
- **Stop Loss:** $171.12 (3.8% risk)
- **Target:** $184.60 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 133
- **Position Value:** $23,655.38
- **Portfolio %:** 23.66%
- **Risk Dollars:** $900.00
- **Risk Per Trade:** 0.90%
- **Modifiers:** L1 120% | L2 75% | Combined 0.90x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with improving risk appetite as VIX falls to 6th percentile and tech rally resumes on AI infrastructure demand. Fed pause expectations from cooling CPI data support equities, though elevated put/call ratio suggests cautious positioning. Focus on quality names in AI-exposed sectors.*

### Earnings

**Next:** 2026-02-03 (Est: $2.04)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.93 | $2.03 | +5.2% |
| 2025Q2 | $1.99 | $2.07 | +4.0% |
| 2025Q1 | $1.64 | $1.75 | +6.7% |
| 2024Q4 | $2.03 | $2.04 | +0.5% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*